As awareness grows regarding the long-term risks associated with progressive myopia, including retinal detachment, glaucoma, myopic macular degeneration, and cataracts, optometrists are increasingly recommending orthokeratology as an effective intervention to slow axial elongation while providing daytime vision correction without glasses or contact lenses.
High awareness of retinal disorders and an established healthcare infrastructure facilitate the adoption of advanced diagnostic technologies. A recent paper published in Optometry & Vision Science highlights key trends and insights regarding the current state of orthokeratology in the U.S. The findings from the Fitting of Orthokeratology in the United States (FOKUS) survey, conducted with over 500 eye care professionals (ECPs), reveal that 56% of those actively fitting ortho-k lenses expect market growth in the coming year. In addition, 46% of ECPs not currently fitting these lenses plan to begin prescribing them within the next two years.
The increase in screen time due to digital devices also plays a crucial role in market growth. A study by the Vision Council reported that over 60% of adults experience symptoms of digital eye strain, leading to heightened awareness regarding eye care and the importance of effective vision correction methods. This trend is driving more individuals to consider ortho-K lenses as a viable solution.
Demand is also being driven by increasing clinical acceptance and practitioner adoption of orthokeratology in the U.S. The Fitting of Orthokeratology in the United States (FOKUS) survey found that approximately 68% of U.S. practitioners prescribe orthokeratology primarily for myopia management, while 56% expect growth in orthokeratology fitting over the following 12 months. In addition, nearly half of practitioners who are not currently offering orthokeratology indicated plans to begin offering the service, reflecting expanding provider availability and growing confidence in the technology. These trends, combined with advancements in corneal topography, customized lens design, and digital fitting software, are making orthokeratology more accessible and efficient for both clinicians and patients.
U.S. Orthokeratology Lens Market Report Segmentation
This report forecasts revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the U.S. orthokeratology lens market report based on type, disease indication, age group, and end-use:Type Outlook (Revenue, USD Million, 2021 - 2033)
- Spherical
- Toric
Disease Indication Outlook (Revenue, USD Million, 2021 - 2033)
- Nearsightedness (Myopia)
- Astigmatism
- Others
Age Group Outlook (Revenue, USD Million, 2021 - 2033)
- 6-12 Years
- 13-19 Years
- 20 Years & Above
End-use Outlook (Revenue, USD Million, 2021 - 2033)
- Optometry Clinics
- Ophthalmology Clinics
- Hospitals
- Others
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
Table of Contents
Companies Mentioned
- Euclid Vision Corporation
- CooperVision
- Contex, Inc.
- Bausch + Lomb.
- Johnson & Johnson
- Art Optical Contact Lens, Inc.
- WAVE Contact Lens System
- TruForm Optics Inc.
- AccuLens

